Rev Fac Cien Med Univ Nac Cordoba
January 2017
Introduction: The end stage renal disease confers a high morbidity and mortality risk, mainly due to cardiovascular disease. The cardiac T troponin and carbohydrate antigen-125 (CA-125) are useful biomarkers to determine cardiovascular prognosis in order to start preventive treatment in the high risk patients.
Methods: We included patients with end stage renal disease in hemodialysis treatment.